7.15/16 Bleeding disorders Flashcards

(44 cards)

1
Q

antibody involved in neonatal alloimmune thrombocytopenia

A

HPA-1a antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

first child often affected in

A

neonatal alloimmune thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

treatment for neonatal alloimmune thrombocytopenia

A

IVIG

corticosteroids

platelet transfusion from mom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

receptor for vWF

A

GPIb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

receptor for fibrinogen

A

GPIIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dilution thrombocytopenia cause by

A

trauma / complicated surgery –> platelets are diluted by saline, red cells, plasma infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens to platelets in ITP

A

IgG binds to platelet, then removed by macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

young female usually has what bleeding disorder

A

ITP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ITP bone marrow

A

increased megakaryocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

first line treatment for ITP

A

corticosteroids

IVIG

anti-D (WinRho) if Rh(D) positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

follows viral illness in children

A

acute immune thrombocytopenia in children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HIV associated thrombocytopenia caused by

A

HIV attacking megakaryocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cause of neonatal thrombocytopenia

A

transplacental passage of maternal autoantibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

end result of HIT

A

thrombin formation, which converts fibrinogen to fibrin clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

lab tests for HIT

A

immunoassays to detect HIT antibodies

serotonin release assay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment for HIT

A

direct thrombin inhibitors (lepirudin, argatroban)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pentad of TTP

A
thrombocytopenia
MAHA
renal dysfunction
neuro disturbances
fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TTP caused by decreased activity of

A

ADAMTS-13 (breaks down sticky ultra large multimers)

19
Q

treatment for TTP

A

plasma exchange

maybe rituximab

20
Q

HUS vs TTP

A

prominent acute renal failure

no neuro sxs

more frequent in kids

normal ADAMTS-13

caused by e coli

not treated by plasma exchange

21
Q

PFA-100 good for detecting

A

meds that affect platelets

vWD

inherited platelet disorders

22
Q

both Bernard Soulier and Glanzmann thrombasthenia are inherited…

A

autosomal recessive

23
Q

Glanzmann thrombasthenia lacks aggregation to

A

ADP
collagen
Epinephrine

24
Q

Bernard Soulier lacks aggregation to

25
Hermansky-Pudlak syndrome
albinism and gamma-storage pool disease (bleeding)
26
to test for aspirin, add what to tube
arachidonic acid
27
to test for clopidogrel, add what to tube
ADP
28
to test for vWD, add what to tube
ristocetin
29
to test for Bernard Soulier, add what to tube
ristocetin
30
if tissue factor was in citrate tube (contaminant), does what to clotting time
decreases it (tissue factor causes clots)
31
if heparin was in citrate tube (contaminant), does what to clotting time
increases it
32
what to rx if bleeding due to liver disease
fresh frozen plasma
33
how does liver disease affect clotting
decreases synthesis of vitamin K dependent factors (so increases PT and PTT)
34
vWD inheritance
autosomal dominant for types 1 and 2 autosomal recessive for type 3
35
if have vWD, will also decrease factor
8
36
variant of vWD that has abnormal vWF
type 2
37
best screening and diagnostic test for vWD
PFA-100 vWF activity (with ristocetin)
38
hemophilia clinical severity correlates with
F8 activity level
39
treatments for vWD
DDAVP (if mild) vWF concentrate anti-fibrinolytics
40
treatment if hemophilia A develops alloantibody to F8
large doses of F8 recombinant 7a (novoseven)
41
what test determines strength of F8 inhibitor (and dictates what treatment to use)
bethesda titer
42
clinical manifestations of DIC
bleeding (obstetric, trauma) thrombosis (cancer)
43
lab values for DIC: ``` platelet D-dimer PT PTT thrombin time fibrinogen ```
``` platelet: decr D-dimer: incr PT: incr PTT: incr thrombin time: incr fibrinogen: decr ```
44
rx management of dic
transfusion anticoagulants fibrinolytic inhibitors (aminocaproic acid)